Preferred Label : EGF Signaling Pathway;
Alternative definition : BIOCARTA: The epidermal growth factor (EGF) peptide induces cellular proliferation
through the EGF receptor. Inhibitors of the EGF receptor are being pursued as potential
cancer therapies and EGF may stimulate wound healing. Mutation of the EGF receptor
has been associated with cancer in humans. The proliferative effects of EGF are signaled
through several pathways. Binding of EGF results in EGF receptor dimerization, autophosphorylation
of the receptor, and tyrosine phosphorylation of other proteins. The EGF receptor
activates ras and the MAP kinase pathway, ultimately causing phosphorylation of transcription
factors such as c-Fos to create AP-1 and ELK-1 that contribute to proliferation. Activation
of STAT-1 and STAT-3 transcription factors by JAK kinases in response to EGF contributes
to proliferative signaling. Phosphatidylinositol signaling and calcium release induced
by EGF activate protein kinase C, another component of EGF signaling. Crosstalk of
EGF signaling with other pathways make the EGF receptor a junction point between signaling
systems. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_egfPathway;
Origin ID : C39058;
UMLS CUI : C1512120;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element